Enzo Biochem (ENZ) Appoints Steven J. Pully to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
October 30, 2023 4:15 PM EDTFARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Â Enzo Biochem, Inc. (NYSE: ENZ) (Enzo or the Company), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Companys Board of Directors effective October 26, 2023. Mr. Pully will assume the role of Chairperson of the Board, and Chair of the Audit Committee as well.
In 2023, Enzo completed the divestiture of Enzo Clinical Labs, Inc. and focused its strategy on growing the life sciences division, said Kara Cannon, Enzos Chief Executive Officer. Steve brings a unique portfolio of legal, corporate governance, and financial... More
